NZS Capital LLC Has $97.31 Million Stake in Danaher Corporation $DHR

NZS Capital LLC grew its stake in Danaher Corporation (NYSE:DHR) by 27.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 490,795 shares of the conglomerate’s stock after acquiring an additional 107,161 shares during the quarter. Danaher accounts for 3.0% of NZS Capital LLC’s portfolio, making the stock its 8th biggest holding. NZS Capital LLC owned about 0.07% of Danaher worth $97,305,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Sivia Capital Partners LLC raised its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the last quarter. Versor Investments LP bought a new stake in shares of Danaher during the second quarter valued at approximately $527,000. Intellectus Partners LLC purchased a new position in Danaher in the 2nd quarter worth approximately $371,000. Corton Capital Inc. bought a new position in Danaher in the 2nd quarter valued at approximately $225,000. Finally, Fullcircle Wealth LLC purchased a new stake in Danaher during the 2nd quarter valued at $644,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 1.0%

Shares of DHR stock opened at $203.97 on Wednesday. The company’s fifty day simple moving average is $224.34 and its two-hundred day simple moving average is $216.20. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The stock has a market cap of $144.24 billion, a P/E ratio of 40.47, a PEG ratio of 2.78 and a beta of 0.93. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the company earned $2.14 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Robert W. Baird set a $251.00 target price on Danaher in a research report on Thursday, January 29th. HSBC raised their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Leerink Partners boosted their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Finally, Argus set a $265.00 price objective on shares of Danaher in a research report on Wednesday, January 14th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.